true
0000310354
0000310354
2024-07-01
2025-06-30
0000310354
2024-12-31
0000310354
2025-07-31
iso4217:USD
xbrli:shares
--06-30FY2025
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Amendment No 1)
FORM 10-K/A
|
☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D)
|
OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended June 30, 2025
|
Commission File Number 001-07233
|
STANDEX INTERNATIONAL CORPORATION
|
(Exact name of registrant as specified in its Charter)
|
Delaware
|
31-0596149
|
(State of incorporation)
|
(I.R.S. Employer Identification No.)
|
23 KEEWAYDIN DRIVE, Salem, New Hampshire
|
03079
|
(Address of principal executive offices)
|
(Zip Code)
|
(603) 893-9701
|
(Registrant’s telephone number, including area code)
|
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934:
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on Which Registered
|
Common Stock, Par Value $1.50 Per Share
|
SXI
|
New York Stock Exchange
|
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein and will not be contained, to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒
|
Accelerated filer ☐
|
Non-accelerated filer ☐
|
Smaller Reporting Company ☐
|
|
|
|
Emerging growth company ☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 USC. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. YES ☒ NO ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☒
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant at the close of business on December 31, 2024 was approximately $2,222,611,330. Registrant’s closing price as reported on the New York Stock Exchange for December 31, 2024 was $186.99 per share.
The number of shares of Registrant's Common Stock outstanding on July 31, 2025 was 12,068,262.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Proxy Statement for the Registrant’s 2025 Annual Meeting of Stockholders (the “Proxy Statement”) are incorporated by reference into Part III of this report.
STANDEX INTERNATIONAL CORPORATION
2025 ANNUAL REPORT ON FORM 10-K/A
EXPLANATORY NOTE
This Amendment on Form 10-K/A (“Amendment No. 1”) amends the registrant’s Form 10-K for the year ended June 30, 2025, as filed with the Securities and Exchange Commission on August 1, 2025 (the “Form 10-K”), solely for the purpose of correcting an inadvertent date error on the signature page in the previously filed 10-K Report. Accordingly, we are filing this Amendment No. 1 to the Form 10-K to include a corrected Signature Page. No other information included in the Form 10-K has been amended and this Amendment No. 1 should be read in conjunction with the Form 10-K. This amendment does not change any previously reported financial results, modify or update disclosures in the Form 10-K, or reflect events occurring after the filing of the Form 10-K.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Standex International Corporation has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, on August 1, 2025.
|
STANDEX INTERNATIONAL CORPORATION
(Registrant)
|
|
|
|
|
|
|
|
|
/s/ DAVID DUNBAR
|
|
|
David Dunbar
|
|
|
President/Chief Executive Officer
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Standex International Corporation and in the capacities indicated on August 1, 2025:
Signature
|
|
Title
|
|
|
|
/s/ DAVID DUNBAR
|
|
President/Chief Executive Officer
|
David Dunbar
|
|
|
|
|
|
|
|
|
/s/ ADEMIR SARCEVIC
|
|
Vice President/Chief Financial Officer and Treasurer
|
Ademir Sarcevic
|
|
|
|
|
|
|
|
|
/s/ DANIELLE RANGEL
|
|
Vice President/Chief Accounting Officer
|
Danielle Rangel
|
|
|
David Dunbar, pursuant to powers of attorney which are being filed with this Annual Report on Form 10-K, has signed below on August 1, 2025 as attorney-in-fact for the following directors of the Registrant:
|
Charles H. Cannon
|
Jeffrey S. Edwards
|
|
|
Thomas E. Chorman
|
Thomas J. Hansen
|
|
|
Robin J. Davenport
|
Michael A. Hickey
|
|
|
B. Joanne Edwards
|
Andy L. Nemeth
|
|
/s/ DAVID DUNBAR
|
|
David Dunbar
|
|
Supplemental Information to be furnished with reports filed pursuant to Section 15(d) of the Act by Registrants which have not registered securities pursuant to Section 12 of the Act.
The Company will furnish its 2025 Proxy Statement and proxy materials to security holders subsequent to the filing of the annual report on this Form. Copies of such materials shall be furnished to the Commission when they are sent to security holders.